Back
iShares S&P 500 Value ETF Vs. Nektar Therapeutics Industry Stock Comparison
Buy
77
IVE
iShares S&P 500 Value ETF
Last Price:
$214.17
Seasonality Move:
2.26%
Sell
45
NKTR
Nektar Therapeutics
Last Price:
$44.55
Seasonality Move:
7.44%
Buy
77
iShares S&P 500 Value ETF (IVE)
is a Buy
Is iShares S&P 500 Value ETF a Buy, Sell or Hold?
-
The current iShares S&P 500 Value ETF [IVE] share price is $214.23. The Score for IVE is 77, which is 54% above its historic median score of 50, and infers lower risk than normal.
-
IVE is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
45
Nektar Therapeutics (NKTR)
is a Sell
Is Nektar Therapeutics a Buy, Sell or Hold?
-
The current Nektar Therapeutics [NKTR] share price is $43.94. The Score for NKTR is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
-
NKTR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
IVE Stock Price Chart
What is iShares S&P 500 Value ETF's stock price today?
-
The iShares S&P 500 Value ETF share price today is $214.23Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and IVE is experiencing slight buying pressure.
NKTR Stock Price Chart
What is Nektar Therapeutics's stock price today?
-
The Nektar Therapeutics share price today is $43.94Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NKTR is experiencing slight buying pressure.
IVE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.11 | Buy |
| Relative Strength Index (14 RSI): | 61.33 | Buy |
| Chaikin Money Flow: | 173431 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (207.98 - 213.66) | Buy |
| Bollinger Bands (100): | (201.9 - 210.78) | Buy |
NKTR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -3.73 | Sell |
| Relative Strength Index (14 RSI): | 36.53 | Sell |
| Chaikin Money Flow: | 129481 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (47.81 - 60.79) | Sell |
| Bollinger Bands (100): | (36.38 - 62.62) | Sell |
IVE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 212.47 | Buy |
| 20-day SMA: | 212.09 | Buy |
| 50-day SMA: | 209.71 | Buy |
| 200-day SMA: | 197.92 | Buy |
| 8-day EMA: | 212.64 | Buy |
| 20-day EMA: | 211.73 | Buy |
| 50-day EMA: | 206.51 | Buy |
| 200-day EMA: | 133.3 | Buy |
NKTR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 46.33 | Sell |
| 20-day SMA: | 53.44 | Sell |
| 50-day SMA: | 56.63 | Sell |
| 200-day SMA: | 32 | Buy |
| 8-day EMA: | 46.62 | Sell |
| 20-day EMA: | 51.01 | Sell |
| 50-day EMA: | 53.13 | Sell |
| 200-day EMA: | 38.51 | Buy |
iShares S&P 500 Value ETF Earnings Growth & IVE Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Nektar Therapeutics Earnings Growth & NKTR Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.41 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.68 per share, and a decrease next year of $3.54 per share.
iShares S&P 500 Value ETF Technical Analysis
| Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Nektar Therapeutics Technical Analysis
| Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||